Effect of photobiomodulation therapy in myogenic temporomandibular disorder patients: a systematic review
Аннотация
Objective Myogenictemporomandibular disorders (TMDs) represent a clinically important subgroup of TMDs in which pain and dysfunction primarily arise from the masticatory musculature. Although photobiomodulation therapy (PBMT) has been investigated as a non-invasive treatment for these disorders, previous systematic reviews have yielded variable conclusions. An updated assessment of the evidence focusing specifically on myogenic TMDs is therefore warranted. The aim of the study was to determine the clinical effectiveness of PBMT for myogenic TMDs and to characterize the treatment parameters applied in randomized controlled trials. Methods A systematic search of PubMed, ScienceDirect, and Google Scholar was performed for studies published from January 2015 through April 2025. Randomized controlled trials involving adults with myogenic TMDs and evaluating PBMT were eligible for inclusion. Outcomes of interest included pain intensity, maximum mouth opening, mandibular function, and quality of life. Risk of bias was evaluated using the Cochrane Risk of Bias 2 (RoB 2) tool. Results Fourteen randomized controlled trials comprising 767 participants were included. Eleven studies demonstrated a statistically significant improvement in at least one assessed primary outcome following PBMT. Reduction in pain was the most consistently reported benefit, with additional improvements reported for maximum mouth opening, mandibular function, and quality of life. Favorable findings were reported in several studies using near-infrared wavelengths, particularly between 780 and 940 nm. Nevertheless, substantial differences in wavelength, power, fluence, irradiation duration, treatment frequency, outcome assessment, and study methodology prevented reliable determination of an optimal PBMT protocol. Conclusion PBMT appears to have potential as a non-invasive intervention for reducing pain and improving selected functional outcomes in individuals with myogenic TMDs. However, considerable variation in treatment protocols and methodological limitations reduces confidence in the available evidence. Well-designed randomized controlled trials using standardized PBMT parameters and validated outcome measures are required to establish optimal treatment protocols and determine the clinical effectiveness of PBMT.